Get started
Author

Ülkü Yılmaz

Observed names: U. Yilmaz, Ulku YILMAZ, Ulku Yilmaz, Ulku Yılmaz, Ulkü YILMAZ, Ulkü Yilmaz, Yılmaz, Ülkü, Ü. Yılmaz, Ülkü YILMAZ, Ülkü YILMAZ TURAY, Ülkü Yilmaz
Observed institutions: Bursa Uludağ Üni̇versi̇tesi̇, Fırat University, Manisa Celal Bayar University, Başkent University, Ondokuz Mayıs University, Ankara Atatürk Eğitim ve Araştırma Hastanesi, Necmettin Erbakan University, Zekai Tahir Burak Kadın Sağlığı Eğitim ve Araştırma Hastanesi, Kayseri Eğitim ve Araştırma Hastanesi, Sağlık Bilimleri Üniversitesi, HSU Dr. Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Turkish Thoracic Society, Ankara Atatürk Göğüs Hastalıkları Ve Göğüs Cerrahisi Eğitim Ve Araştırma Hastanesi, Ankara Eğitim ve Araştırma Hastanesi, Eskişehir Osmangazi University, Gazi University
ORCID: 0000-0003-1493-8385
Observed ORCID: 0000-0003-1493-8385
OpenAlex ID: A5061325374
Turkey National Mesothelioma Surveillance and Environmental Asbestos Exposure Control Program
2017 · Selma Metintaş, Hasan Fevzi Batırel, et al. · International Journal of Environmental Research and Public Health · 51
PDF
Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes
2021 · M. Alper Kursunel, Ekim Z. Taskiran, et al. · Cancer Immunology Immunotherapy · 43
PDF
Rapid diagnosis of malignant pleural mesothelioma and its discrimination from lung cancer and benign exudative effusions using blood serum
2022 · Dilek Yonar, Mete Severcan, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 39
Lung Cancer in Turkey
2022 · Ayten Kayı Cangır, Perran Fulden Yumuk, et al. · Journal of Thoracic Oncology · 22
PDF
High FDG uptake predicts poorer survival in locally advanced nonsmall cell lung cancer patients undergoing curative radiotherapy, independently of tumor size
2014 · Sukran Ulger, Nilgun Yilmaz Demirci, et al. · Journal of Cancer Research and Clinical Oncology · 20
Anxiety and depression levels of healthcare workers during the Covid-19 pandemic
2022 · Onur Turan, Nilgün Yılmaz Demirci, et al. · African Health Sciences · 19
PDF
Serological Evaluation of Bordetella pertussis Infection In Adults With Prolonged Cough
2016 · Cemile SÖNMEZ, Nilay ÇÖPLÜ, et al. · Mikrobiyoloji Bulteni · 13
The success of non‐invasive mechanical ventilation in lung cancer patients with respiratory failure
2021 · Derya Kızılgöz, Pınar Akın Kabalak, et al. · International Journal of Clinical Practice · 11
PDF
Characteristics of hospitalised COVID‐19 patients and parameters associated with severe pneumonia
2021 · Onur Turan, Arzu Mirici, et al. · International Journal of Clinical Practice · 10
Evaluation of Exudative Pleural Effusions: A Multicenter, Prospective, Observational Study
2022 · Guntulu Ak, Selma Metintas, et al. · Lung · 8
Definitive chemoradiotherapy in Stage III nonsmall cell lung cancer: Turkey experience
2016 · Zehra Yasar, Ufuk Yilmaz, et al. · Journal of Cancer Research and Therapeutics · 8
Prognostic significance of preoperative consolidation to maximum tumour diameter ratio and SUVmax in pathological stage I lung adenocarcinoma
2019 · Pınar Akın Kabalak, Ülkü Yılmaz, et al. · The Clinical Respiratory Journal · 5
Could PD-L1 positivity be associated with venous thrombosis in patients with non-small cell lung cancer?
2022 · Yasemin Söyler, Pınar Akın Kabalak, et al. · Journal of Thrombosis and Thrombolysis · 4
The association of clinicopathologic features and peripheral blood parameters with high PD-L1 expression in non-small cell lung cancer
2020 · Burak BİLGİN, Mutlu HIZAL, et al. · Tuberkuloz ve Toraks · 4
PDF
Immunotherapy and multidisciplinary approach to treatment in lung cancer
2020 · Nuri KARADURMUŞ, Akın KAYA, et al. · Tuberkuloz ve Toraks · 4
PDF
Treatment outcomes in oligometastatic non‐small‐cell lung cancer: A single‐centre experience
2020 · Pınar Akın Kabalak, Derya Kızılgöz, et al. · The Clinical Respiratory Journal · 4
Could SUVmax be an auxiliary parameter in the clinical management of pulmonary hydatid disease?
2018 · Ozlem Ozmen, Ebru Tatci, et al. · The Clinical Respiratory Journal · 4
Comparison of seventh TNM and eighth TNM staging system in stage III non–small cell lung cancer patients treated with concurrent chemoradiotherapy
2018 · Ufuk Yılmaz, Özer Özdemir, et al. · Current Problems in Cancer · 4
Use of FDG PET/CT in Patients with Pancoast Tumors: Does It Add Any Contribution to Patient Management?
2015 · Ozlem Ozmen, Ulku Yilmaz, et al. · Cancer Biotherapy and Radiopharmaceuticals · 4
The efficacy of 18F-FDG PET/CT in monitoring disease progression in malignant pleural mesothelioma
2022 · Yasemin Söyler, Özlem Özmen, et al. · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · 3
Treatment Approaches in Lung Cancer
2018 · Ülkü Yılmaz · Nuclear Medicine Seminars · 3
PDF
Different approach to M descriptor for future staging of oligometastatic disease in SCLC: A cross-sectional survival analysis
2024 · Melahat Uzel Şener, Pınar Akın Kabalak, et al. · Clinical & Translational Oncology · 2
Potential role of pre-treatment bone marrow SUVmean to liver SUVmean ratio (BM/L) and comparison of primary tumour FDG uptake with brain FDG uptake in predicting survival in limited-stage lung cancers
2023 · Suna Kavurgaci, Özlem Özmen, et al. · Nuclear Medicine Communications · 2
Clinical Presentation of Lung Cancer
2023 · Pınar Akın Kabalak, Ülkü Yılmaz · Springer eBooks · 2
Immunotherapy for Lung Cancer
2023 · Nuri KARADURMUŞ, Nalan AKYÜREK, et al. · Journal of Oncological Sciences · 2
PDF
Works count: 87
Citation count: 317
H-index: 9
I10-index: 9
Year
Topic
Type